Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Phacoemulsification Surgery and Intravitreal Triamcinolone Injection Versus Stand-alone Surgery in Patients With Type 2 Diabetes: A Randomized Controlled Trial

NCT05413330 is registered in ClinicalTrials.gov with Damascus University as lead sponsor.

NCT NCT05413330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05413330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Phacoemulsification Surgery and Intravitreal Triamcinolone Injection Versus Stand-alone Surgery in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Lead sponsor
Damascus University
Phase
Phase 2/3
Overall status
Completed
Start date
September 12, 2020
Completion date
March 29, 2022
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, diabete type 2, intravitreal injection, triamcinolone acetonide